131I-MIBG therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 131I-MIBG therapy, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma [Phase 1]